The effects of fl-adrenergic agonists on ATP utilization and adenine nucleotide breakdown in human adipocytes were examined. The catecholamine-induced increase in cAMP was associated with an enhancement of adenine nucleotide catabolism resulting in an increase in release of inosine and hypoxanthine which can not be reutilized for adenine nucleotide synthesis. Therefore, one-third of total cellular adenine nucleotides were irreversibly lost in the presence of 1 gnmol/liter isoproterenol.
Introduction
It is well established that the activation of lipolysis by hormones may be associated with a decrease in ATP (1) (2) (3) . The stimulatory effects of lipolytic hormones are mediated by cAMP (4) . The concentrations of the cyclic nucleotide required to produce an increase in lipolytic activity are in the micromolar concentration range, while ATP concentrations are in the range of 5-10 mmol/liter (4) . Accordingly, it is a widely held belief that ATP utilization via adenylate cyclase is small in relation to total ATP turnover, even when adenylate cyclase is maximally activated (4) .
The hydrolysis of triglycerides does not require metabolic energy. Therefore, the effects of the products of lipolysis, e.g., FFA and glycerol, on energy metabolism as well as the energetic requirements of their further metabolism have received considerable attention (1) (2) (3) (4) (5) (6) (7) (8) (9) . Glycerol cannot be metabolized by human adipose tissue (5) (6) (7) (8) . By contrast, FFA can be degraded or reesterified (1) (2) (3) (4) (5) (6) (7) (8) (9) . The triglyceride-FFA cycle requires metabolic energy and generates heat (5) (6) (7) (8) . In addition, FFA can uncouple oxidative phosphorylation and this effect may contribute to the drop in ATP seen in the absence of albumin, or when the FFA to albumin ratio in the media exceeds a value of 6 (1-3, 9).
A major problem in the determination of ATP turnover via adenylate cyclase has been the evaluation of the role(s) of phosphodiesterase(s). Quantitative estimates of the rates of cAMP hydrolysis revealed that, in contrast to commonly held views, human platelets display high rates of cAMP turnover even in the absence of activators (10) . When rat adipocytes are incubated at low densities or in the presence of adenosine deaminase, most of the ATP may be converted to cAMP within minutes in the presence of lipolytic activators (1 1, 12) . Accordingly, hormone-activated rates ofcAMP turnover ofrat adipocytes were too rapid to be quantified by current methodology (1 3).
Hydrolysis of cAMP yields AMP that is the first substrate of catabolic reactions ( 14) . Any increase in its rate of synthesis can therefore lead to its further metabolism by dephosphorylation or deamination (14) . Indeed, previous studies from this laboratory revealed that isoproterenol caused an increase in the release of inosine and hypoxanthine in human adipocytes which appeared to be related to ATP turnover via adenylate cyclase (15) . The current studies are a detailed investigation into the interrelationship between lipolytic activity, cAMP accumulation, adenine nucleotide breakdown, and purine release in human adipocytes. It is shown that adenylate cyclase may constitute a major route of ATP utilization in human adipocytes in the presence of,-adrenergic agonists. The increase in cAMP is associated with an enhanced release of purines that cannot be reutilized for adenine nucleotide synthesis. Prolonged f,-adrenergic stimulation therefore leads to an irreversible depletion of cellular energy stores.
Methods

Subjects
Fat tissue was from female subjects undergoing elective abdominal or cosmetic breast surgery who were not selected on the basis of age or weight. The subjects were operated on after an overnight fast. Anesthesia was initiated with a short-acting barbiturate and maintained with halothane, nitrous oxide, and oxygen.
Preparation offat cells
Tissue specimens were cut into small pieces and fat cells were isolated by the method of Rodbell (16) At the times indicated, 0.3 ml of suspensions were removed and extracted by 1 mol/liter perchloric acid. Another aliquot of suspensions was centrifuged through silicone oil (6,000 g, 10 s). 0.2 ml of the cell-free infranatants were transferred to perchloric acid for determination of cAMP, adenine nucleotides, and fatty acids. The remaining portion ofthe media (0.8 ml) was inactivated by heating (95°C, 5 min) and assayed for glycerol and purines. Assays FFA andglycerol. FFA were determined bioluminometrically (17) . To increase the dynamic range and speed of fatty acid conversion, the concentrations ofATP, CoA, fructose-6-phosphate, and acyl-CoA synthetase were increased. The medium for conversion of fatty acids contained 23 mmol/liter Hepes, pH 8.0, 1 33 U/ml triosephosphate isomerase, 280 mU/ml aldolase, 18 mU/ml glyceraldehyde phosphate dehydrogenase, 35 mU/ml acyl-CoA synthetase, and 100 mU/ml of the pyrophosphate-dependent fructose-6-phophate kinase. 0.05-ml samples were added to an equal volume of conversion medium and incubated for 1 h at 25°C. After appropriate dilution (10 times) samples were assayed for fatty acid contents as described (17) . Human serum albumin (Behring Werke Marburg, Marburg, FRG) contained 1 rmol/g fatty acids leading to blank values of20 Mmol/liter, a figure that permitted a determination of FFA release without prior delipidation. Glycerol was determined as published (18) .
Purines. Adenosine, inosine, and hypoxanthine were measured by a chemiluminescent method using the peroxidase/luminol system as indicator reaction (19 (15) .
Results
Effects ofisoproterenol on lipolysis, cAMP accumulation, and adenine nucleotide concentrations. Fig. 1 shows time courses of glycerol and FFA release in the presence and absence of 1 gmol/liter isoproterenol. The changes in cAMP and adenine nucleotide concentrations were monitored simultaneously (Fig. 2) . On the average, isoproterenol caused a fourfold increase in lipolytic activity. Isoproterenol-activated rates of lipid mobilization proceeded at linear rates. The molar FFA to glycerol ratio was close to the theoretical value of 3:1 in the absence and presence of isoproterenol, indicating that no reesterification took place under the conditions used. In another series of experiments (n = 4) carried out in the presence of 10 Amol/liter a,f-methylene adenosine 5'-diphosphate and 10 mmol/liter ,B-glycerophosphate -15% of the fatty acids produced were recycled back to triglycerides in the absence and presence of isoproterenol (not shown).
Human adipocytes contained 20-30 nmol/106 cells adenine nucleotides (Fig. 2) . In controls the adenine nucleotides~~~r Fig. 1 , and refer to the nucleotide contents of suspensions. Extracellular adenine nucleotide concentrations corresponded to < 10% of total cellular adenine nucleotide contents under these conditions. Symbols are the same as in Fig. 1 .
were 74+6% ATP, 16±7% ADP, and 10±5% AMP. cAMP levels were < 1%. The concentrations of ATP and total adenine nucleotides displayed an initial decline by ! 25%, followed by a partial recovery, which may reflect a salvage of adenosine. Accordingly, the latter effect was not observed in the presence of dipyridamole, an inhibitor of nucleoside transport (not shown).
In the presence ofisoproterenol (1 gmol/liter) ATP became depleted to less than one-half of control levels ( Fig. 2 A) . Concomitantly, cAMP concentrations rose to 8±1.5 nmol/106 cells (Fig. 2 D) . The initial rise in cAMP was followed by a gradual decline lasting > 2 h. In the rat the decline in cAMP was associated with a marked increase in AMP (1.1, 21) . By contrast, in human adipocytes virtually no increase in AMP was observed in conventional incubations, i.e., in the absence of inhibitors of ectophosphatase activities (Fig. 2 C) . As ADP levels also remained unchanged (Fig. 2 B) , the isoproterenolinduced drop in ATP was reflected by a corresponding decrease in total adenine nucleotide contents (Fig. 2 D) .
Cell integrity and catabolism of extracellular adenine nucleotides. Human adipocytes are fragile (22) . In standard incubations 8±2% of total cellular LDH activity was recovered in the media at the start of incubations. A further 8±2% was released per hour ofincubation. During rapid time courses cell leakage was two to three times higher due to the more frequent agitation of suspensions (Table I) . Catecholamines had no detectable influence on LDH release up to a concentration of 1 ,umol/liter. Caution needs to be exercised at higher catecholamine concentrations, however. At 10 Mmol/liter LDH release may be increased up to twofold in some preparations, while no additional damage is observed in others (see legend to Fig. 3 ).
Human adipocytes possess ectophosphatases that are capable ofsequentially degrading ATP to adenosine (15) . Considering the short-lived integrity of the cells, it appeared important to discriminate between adenine nucleotide catabolism from broken cells, occurring extracellularly, and intracellular adenine nucleotide breakdown. Therefore, all subsequent experiments were carried out in the presence of 10 amol/liter a,#-methylene adenosine 5'-diphosphate and 10 mmol/liter 8-glycerophosphate, which block the extracellular catabolism of ATP at the level ofAMP (23, 24). The validity of this approach has been documented.2 Nonspecific losses of ATP result in a corresponding accumulation of ADP and AMP in the media under these conditions (Table I) . Accordingly, the extracellular concentrations of these latter nucleotides (and cAMP) are related to LDH release in the absence and presence of isoproterenol, and no adenosine can be detected in the media because the extracellular catabolism of AMP is blocked (15) . Notably, isoproterenol had only marginal effects, if any, on the intracellular concentrations of ADP and AMP in the presence of (Table I) , consistent with the results obtained in conventional incubations (Fig. 2) . Effects of increasing concentrations of various catecholamines. Fig. 3 shows the effects of various concentrations of isoproterenol and epinephrine on cAMP levels, purine release, ATP, and the sum of individual adenine nucleotides. In contrast to isoproterenol, which is highly selective for f3-adrenergic receptors, epinephrine has opposing a2-and fl-adrenergic effects on lipolysis and cAMP accumulation in human adipocytes (25) . The effects ofthe naturally occurring catecholamine were therefore assessed in the absence and presence of the a2-blocking agent, yohimbine. Isoproterenol caused a concentration-dependent increase in cAMP which was half maximal at 0.3 umol/liter (Fig. 3 A) . Maximal (Fig. 3 A) .
As shown in a preceeding paper (15) , intact human adipocytes release extremely small amounts of adenosine, if any, irrespective of whether ATP turnover is increased by isoproterenol or not. Accordingly, the medium concentrations ofthis nucleoside were beyond detectable levels in the presence of a,/3-methylene adenosine 5'-diphosphate and ,B-glycerophosphate. In contrast, isoproterenol and epinephrine (in the simultaneous presence of yohimbine) caused a marked increase in inosine and hypoxanthine release which closely resembled their cAMP-elevating effects with respect to relative efficacy and rank order of potency (Fig. 3 B) .
The stimulatory effects of both catecholamines on cAMP accumulation and purine release were inversely mirrored by a u Cc0i AM°IO-i decrease in ATP and the sum of individual adenine nucleotides (Fig. 3, C and D) . All responses could be reversed by the fl-blocking agent propranolol, indicating that they were mediated via a f3-adrenergic receptor (Table II) .
Somewhat surprisingly, isoproterenol and epinephrine (in the simultaneous presence of yohimbine) were more potent ( 10-fold) in stimulating purine release than in increasing cAMP. This is more clearly illustrated in Fig. 4, showing (26) . Therefore, the relationship between cAMP accumulation and purine release was studied in detail at different concentrations of isoproterenol (Fig. 5 ). There was a slight shift in the peaks of cAMP accumulation from shorter to longer times with increasing concentrations of isoproterenol (Fig. 5 A) . In addition, cAMP levels tended to decline more slowly at high concentrations of the fl-adrenergic agonist. Overall, the kinetic variability of cAMP accumulation was small, however, in relation to the marked difference in isoproterenol sensitivity noted between cAMP accumulation and purine release, indicating that this discrepancy is a real one (Fig. 5 B) .
An unexpected outcome of these studies was that purine release ceased as soon as cAMP had attained a relatively stable level, irrespective of whether cAMP levels remained markedly elevated or not. This is illustrated in Fig. 6 showing a balance of adenine nucleotide breakdown and formation of products, e.g., cAMP and purines. In controls, cAMP accumulation was negligible (-0.05 nmol/106 cells), and purine release corre- sponded to < 10% of cellular adenine nucleotide contents. After a small initial drop, adenine nucleotide concentrations, therefore, remained essentially unchanged in the course of incubations (Fig. 6 B) .
Isoproterenol caused a drop in adenine nucleotide concentrations by half. Initially the decrease in adenine nucleotide concentrations could be mainly accounted for by the isoproterenol-induced increase in cAMP. The subsequent transition to a lower relatively stable cAMP level was counterbalanced by the ongoing release of purines. Thereafter purine release ceased even though cAMP concentrations were still > 100 times above basal levels. Concomitantly, adenine nucleotide concentrations were stabilized at the same low level that was initially attained, and the sum of cAMP and purines closely corresponded to the decrease in adenine nucleotide concentrations in the whole course of incubations (Fig. 6 A) . Consistently, propranolol could only prevent the isoproterenol-induced increase in purine release when added at the start of incubations, but had little effect after 30 min (Table II) .
Effects ofphosphodiesterase inhibitors. The isoproterenolinduced drop in ATP and total adenine nucleotides could be the result of increased substrate consumption via adenylate cyclase as well as increased ATP-utilizing activities that are stimulated by the elevated cAMP level. cAMP became a major adenine nucleotide in the presence of maximal concentrations of fl-adrenergic agonists, suggesting that the former mechanism is the more important one. The latter concept implies that phosphodiesterase is one of the critical steps in the chain of events leading to a hormone-induced increase in adenine nucleotide catabolism. Mmol/liter isoproterenol (Fig. 7 , Table III ). The inhibition of purine release was associated with a marked increase in cAMP, indicating that the cyclic nucleotide is in fact the main precursor of purines in the presence of isoproterenol (Fig. 7 , Table III).
Reversibility ofthe catecholamine-induced decrease in adenine nucleotide concentrations. As shown in a recent report (15) , adenosine was avidly taken up and incorporated into cellular adenine nucleotides (Table IV) . In contrast to adenosine, the concentrations of exogenously supplied inosine and hypoxanthine (1 ,mol/liter) dropped by < 10% within 3 h, indicating that human adipocytes can reutilize only small amounts of these latter purines, if any (Table IV) . Along with the observation that ,B-adrenergic agonists caused a selective increase in inosine and hypoxanthine release, the latter finding strongly suggested that the catecholamine-induced drop in cellular adenine nucleotide contents is largely irreversible.
To substantiate this contention suspensions were incubated in the absence and presence of isoproterenol, either alone or in combination with the phosphodiesterase inhibitor, Ro enol was terminated by 2 umol/liter propranolol and incubations were continued for another 60 min (Fig. 7) . Propranolol had no influence on purine release when added after 30 min, consistent with the data shown in Table II . By contrast, cAMP concentrations rapidly declined after addition of the #-blocking agent (Fig. 8 A) . The cAMP that was still present 15 min after addition of propranolol was almost quantitatively recovered in the media, indicating that the intracellular concentrations of the cyclic nucleotide had approached basal levels. Concomitantly, adenine nucleotide concentrations rose to a new steady level which was, however, lower than the initial one (Fig. 8 C) . The difference between the initial and final adenine nucleotide concentrations closely corresponded to the sum of cAMP and purines recovered in the media, indicating that the catecholamine-induced depletion of ATP and total cellular adenine nucleotides is in fact largely irreversible (Fig. 8 C) .
In the presence of a maximally effective concentration of Ro 20-1724 (0.75 mmol/liter), the isoproterenol-induced increase in cAMP was doubled (Fig. 8 B) . The phosphodiesterase inhibitor delayed the decay ofcAMP as expected. However, its influence on the activity of phosphodiestere(s) in situ was relatively small. The half-life ofcAMP was -4 min in the absence of the phosphodiesterase inhibitor and 7.5 min in its presence. As cAMP concentrations were doubled by Ro 20-1724, it is (Fig. 8 B) . In contrast to controls (Fig. 8, A and C) , the isoproterenol-induced drop in adenine nucleotide concentrations was almost completely reversible in the presence of Ro 20-1724 (Fig. 8 D) . The relatively small losses of cellular adenine nucleotides (-10%) could be mainly accounted for by the amount of cAMP recovered in the media under these latter conditions (Fig. 8 D) .
Discussion
It is well established that ,B-adrenergic stimulation of fat cell lipolysis may be associated with a pronounced drop in ATP (1-3) . However, no previous study has followed the concentrations of other adenine nucleotides and their degradation products in a manner adequate for a quantitative assessment ofthe pathways ofenergy metabolism in adipocytes. The present study demonstrates that in human adipocytes the ATPlowering action of ,B-adrenergic catecholamines is almost entirely due to their cAMP-elevating property. The hydrolysis of cAMP is associated with a stimulation of adenine nucleotide breakdown which leads to an irreversible loss of adenine nucleotides. Effects ofcatecholamines on cAMP levels and adenine nucleotide concentrations. The rate of adenine nucleotide breakdown may be accelerated by an increase in ATP utilization, a decrease in the ability of cells to phosphorylate ADP and AMP, or both these mechanisms (14) . As nearly three times more fatty acids were released than glycerol, an increase in ATP utilization due to an activation of the lipolysis-reesterification cycle can be ruled out (4-7). Likewise, an inhibition of ATP synthesis by uncomplexed fatty acids is unlikely to play a role because the molar FFA to albumin ratio was < 3:1 in the present experiments, indicating that the tight-binding capacity of albumin for fatty acids had not been exceeded (27) . The pathway involving cAMP formation and hydrolysis is generally not considered a major route of ATP utilization (4) . By contrast, in the present experiments the majority of ATP was converted to cAMP within 15 min in the presence of isoproterenol (Figs. 2 and 6 ). The latter finding points out the considerable potential ofadenylate cyclase and demonstrates that the pathway involving the formation and hydrolysis of cAMP assumes a major role in ATP utilization in the presence of maximally effective concentrations of f-adrenergic catecholamines. Similar observations were made in the rat (11, 21) . However, in rat adipocytes the catecholamine-induced drop in ATP was associated with a major change in adenine nucleotide distribution (i.e., AMP became the predominant nucleotide), while the sum of individual adenine nucleotides displayed no major change (1 1, 21) . By contrast, in human adipocytes the concentrations of ADP and AMP were not substantially altered in spite of a marked drop in ATP. Along with the observation that cAMP levels remained elevated for > 1 h in the presence of maximal concentrations of fl-adrenergic agonists, the latter finding suggests that the rate of AMP formation is largely determined by the velocity of cAMP hydrolysis in the presence of f3-adrenergic agonists.
Once formed, AMP may be reconverted to ATP through the action of adenylate kinase or degraded by deamination and/or dephosphorylation (14) . In human adipocytes AMP breakdown takes place primarily by deamination.2 Indeed, the catecholamine-induced increase in ATP turnover via adenylate cyclase resulted in a concentration-dependent increase in release of inosine and hypoxanthine, which cannot be reutilized for adenine nucleotide synthesis by human adipocytes. Accordingly, the catecholamine-induced drop in ATP and total adenine nucleotide concentrations was largely irreversible. Overall, the current data thus strongly suggest that the pathway involving cAMP formation and hydrolysis not only assumes a major role in ATP utilization (which is reversible), but also constitutes the principle route of irreversible adenine nucleotide catabolism in the presence of,3-adrenergic agonists.
Role ofphosphodiesterase. Recent studies in rat adipocytes demonstrated a reversible drop in ATP in the simultaneous presence of phosphodiesterase inhibitors and catecholamines (11) . Consistently, the irreversible loss of preformed purine bases was prevented by this type of drug in the current experiments, and the isoproterenol-induced depletion of cellular adenine nucleotide contents was nearly fully reversible (Fig. 8) . The use of phosphodiesterase inhibitors is not simple, however, in that they cause only transient inhibition of cAMP hydrolysis in situ, and may show other effects as well (28) . Since the inhibitory effects of IBMX and Ro 20-1724 on catecholamine-induced adenine nucleotide catabolism were associated with an excessive increase in cAMP, an effect ofboth on phosphodiesterase may be inferred (Fig. 7) . Furthermore, as discussed below, the stimulatory effects of fl-adrenergic agonists on purine release appear to be related to the initial burst of cAMP turnover, and this explains why IBMX and Ro 20-1724 were capable of completely suppressing adenine nucleotide catabolism, even though their inhibitory effects were rapidly overcome in association with increasing levels of cAMP. Overall, it thus appears that the catecholamine-induced loss of preformed purine bases is in fact critically dependent on phosphodiesterase activity.
Phosphodiesterase exists in multiple forms which vary widely in substrate affinities and mode of regulation (26, (28) (29) (30) (31) (32) . Among the at least three isoforms that are present in rat fat cells, a low Km cAMP phosphodiesterase has been identified that is activated by catecholamines (presumably through the action of a cAMP-dependent protein kinase; 31). The enzyme is also present in human adipocytes (30) . The issue of whether or not the increase in enzyme activity observed in broken cell preparations relates to the intact cell remains to be clarified. It is, therefore, difficult to decide whether the catecholamine-induced acceleration of AMP catabolism is solely due to increased availability of its precursor cAMP, or reflects (at least in part) regulatory influences at the level of hormonesensitive cAMP phosphodiesterase. The striking parallelism between the cAMP-elevating properties of epinephrine and isoproterenol and their stimulatory effects on purine release suggests that increased substrate availability is one of the factors that are causally involved. However, both catecholamines were more potent in stimulating purine release than in eliciting an increase in cAMP. A series of reports, including this study, have shown that a similar discrepancy exists between the cAMP-elevating properties of catecholamines and their stimulatory effects on lipolysis, which may reflect a compartmentation of the cyclic nucleotide, but could be caused by other mechanisms as well (32) (33) (34) . The former possibility is supported by the work of Goldberg et al. demonstrating stimulusinduced increases in cyclic nucleotide turnover which were transient, and appeared to reflect a highly coordinated increase in cyclic nucleotide formation and hydrolysis confined to functionally important pools (10) . The observation that purine release ceased as soon as cAMP had attained relatively stable levels strongly suggests that similar mechanisms are operative in human adipocytes (Fig. 6) . As cAMP levels remained markedly elevated, the progressive decrease in purine release can be classified as a homologous type of desensitization (4). Intriguingly, partially purified preparations of hormone-sensitive fat cell phosphodiesterase display the same type of response during sustained ,B-adrenergic stimulation (32) . The questions of whether and to what extent the stimulatory effects of catecholamines on purine release reflect their effects on hormone-sensitive phosphodiesterase, therefore, deserve further investigation.
Physiological considerations. Previous work from this and other laboratories revealed that the elimination of inhibitory influences is sufficient for fat cells to achieve lipolytic activities that are comparable with those observed in the presence of a maximal concentration of isoproterenol (35) (36) (37) . As activating hormones are not necessary for a maximal stimulation oflipid mobilization, it was concluded that human fat cell lipolysis needs to be inhibited before it can be activated by lipolytic hormones (37) . By demonstrating that unopposed stimulatory inputs can lead to an irreversible depletion of cellular energy stores, the present findings provide further arguments in support of the view that a certain degree of inhibition is essential for the maintenance of metabolic homoiostasis in fat cells.
Along this line of reasoning it is difficult to understand why the cells fail to release adenosine, which, in contrast to inosine and hypoxanthine, is capable of preventing an excessive production of cAMP and can be reutilized for adenine nucleotide synthesis (1 1, 12, 35-37) . In vivo, the interstitial fluid of human adipose tissue appears to contain adenosine, however, which may be derived from the circulation or produced locally by vascular stromal cells or neurons (38) . In addition, epinephrine and norepinephrine are the only hormones that have been demonstrated to be of physiological importance as stimulators of lipid mobilization in adult humans (22) . Both hormones have antagonistic a2-and fl-adrenergic components of action (25) . Therefore, the degree of fl-adrenergic stimulation observed in the presence of maximal concentrations of isoproterenol will never occur in vivo (Fig. 3) . The questions of whether and how a dual regulation of a single metabolic pathway by a single class of hormones might offer advantages over an unidirectional type of control have not been satisfactorily answered until now. This study points out that this type of regulation may play a role in minimizing the energy that is wasted by signal transmission, implying that rat adipocytes that are devoid of functional a2-adrenergic receptors might be more dependent on inhibitory regulators such as adenosine than human adipocytes (22 (42) . It is therefore doubtful whether the oxidative capacity of this energetically wasteful tissue is large enough to make a substantial contribution to energy expenditure in man. The present findings document that white fat cells have an enormous potential for dissipating energy in response to fladrenergic catecholamines, suggesting that white adipose tissue, which is present in excessive amounts in the obese, may be a much more important target ofthermogenic drugs in human beings than brown adipose tissue.
In conclusion, it is shown that fl-adrenergic activation of human fat cell lipolysis results in a marked increase in inosine and hypoxanthine release which is closely related to cAMP accumulation. In contrast to adenosine, inosine and hypoxanthine cannot be reutilized for adenine nucleotide synthesis.
Unopposed fl-adrenergic stimulation therefore leads to an irreversible loss of cellular adenine nucleotides which is not seen in the presence of the naturally occurring hormone, epinephrine, acting through a2-and fl-adrenergic receptors.
